This information was published on 2025-08-14T10:03:13 for IP Right Registration Published.
| Field | Value |
| (210) | 2513415 |
| (220) |
14 Jan 2025
|
| (300) |
US, 06 Jan 2025, 98939754
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases. |
| (540) | YOURITY |
| (550) | Word |
| (730) |
Eli Lilly and Company
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.